| REED JOHN C |
Officer |
Oct 17 '25 |
Proposed Sale
|
192.71 |
21,721 |
4,185,794 |
|
Oct 17 10:23 AM
|
| REED JOHN C |
EVP, Innovative Medicine, R&D |
Oct 17 '25 |
Sale
|
192.71 |
21,721 |
4,185,793 |
10,658 |
Oct 20 07:13 PM
|
| Taubert Jennifer L |
EVP, WWC. Innovative Medicine |
Sep 04 '25 |
Sale
|
177.81 |
56,471 |
10,040,883 |
178,013 |
Sep 05 06:00 PM
|
| Taubert Jennifer L |
Officer |
Sep 04 '25 |
Proposed Sale
|
177.81 |
56,471 |
10,040,904 |
|
Sep 04 02:37 PM
|
| Forminard Elizabeth |
Executive VP, General Counsel |
Aug 29 '25 |
Option Exercise
|
115.67 |
11,521 |
1,332,634 |
22,423 |
Sep 03 05:13 PM
|
| Forminard Elizabeth |
Officer |
Aug 29 '25 |
Proposed Sale
|
177.20 |
9,570 |
1,695,806 |
|
Aug 29 03:36 PM
|
| Duato Joaquin |
Officer |
Aug 22 '25 |
Proposed Sale
|
180.03 |
125,824 |
22,652,724 |
|
Aug 22 01:58 PM
|
| Duato Joaquin |
CEO and Chairman of the Board |
Aug 22 '25 |
Sale
|
179.21 |
125,824 |
22,548,655 |
275,967 |
Aug 25 07:12 PM
|
| Wolk Joseph J |
Exec VP, CFO |
Aug 15 '25 |
Sale
|
176.91 |
16,820 |
2,975,571 |
14,000 |
Aug 18 06:19 PM
|
| Wolk Joseph J |
Officer |
Aug 15 '25 |
Proposed Sale
|
176.91 |
16,820 |
2,975,571 |
|
Aug 15 03:57 PM
|
| REED JOHN C |
EVP, Innovative Medicine, R&D |
Jul 17 '25 |
Sale
|
163.55 |
19,137 |
3,129,830 |
10,658 |
Jul 18 04:12 PM
|
| REED JOHN C |
Officer |
Jul 17 '25 |
Proposed Sale
|
163.55 |
19,137 |
3,129,831 |
|
Jul 17 04:05 PM
|
